Number of the records: 1  

Reductive carboxylation and 2-hydroxyglutarate formation by wild-type IDH2 in breast carcinoma cells

  1. 1.
    0446813 - FGÚ 2016 RIV GB eng J - Journal Article
    Smolková, Katarína - Dvořák, Aleš - Zelenka, Jaroslav - Vítek, L. - Ježek, Petr
    Reductive carboxylation and 2-hydroxyglutarate formation by wild-type IDH2 in breast carcinoma cells.
    International Journal of Biochemistry and Cell Biology. Roč. 65, AUG 15 (2015), s. 125-133. ISSN 1357-2725. E-ISSN 1878-5875
    R&D Projects: GA ČR(CZ) GPP301/12/P381; GA MŠMT(CZ) LF14001
    Institutional support: RVO:67985823
    Keywords : reductive carboxylation * NADPH-dependent isocitrate * dehydrogenase IDH2 * hypoxia * 2-hydroxyglutarate
    Subject RIV: FD - Oncology ; Hematology
    Impact factor: 3.905, year: 2015

    We quantified CO2–dependent reductive carboxylation glutaminolysis (RCG) and CO2–independent 2HG production in HTB-126 and MDA-MB-231 breast carcinoma cells by measuring 13C incorporation from 1-13C-glutamine into citrate, malate, and 2-hydroxyglutarate (2HG), for which we found a substantial enrichment that ceased upon IDH2 silencing. Relatively high basal 12C-2HG levels existed (5-fold higher vs. non-tumor HTB-125 cells) and 13C-2HG was formed despite the absence of any idh2 and idh1 mutations in HTB-126 cells. Since RCG is enhanced at hypoxia (frequent in solid tumors) and 2HG can be formed without idh1/2 mutations, we suggest 2HG as an analytic marker (in serum, urine, or biopsies) predicting malignancy of breast cancer in all patients
    Permanent Link: http://hdl.handle.net/11104/0248780

     
     
Number of the records: 1  

  This site uses cookies to make them easier to browse. Learn more about how we use cookies.